Text this: ANTI-INTERLEUKIN-17 MONOCLONAL ANTIBODY FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS OF ANALYSIS OF A RUSSIAN PATIENT GROUP FROM THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MEASURE 1 AND MEASURE 2 TRIALS